Lingkai Kong
Impact in
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Virus-based gene therapy research
Papers in
- Genetics 8
- Virus-based gene therapy research 8
-
- RNA modifications and cancer 2
- Co-authors
- Junhua Wu (10 shared papers)Shuguang Zuo (4 shared papers)Jie Dong (4 shared papers)Jiwu Wei (4 shared papers)Min Wei (3 shared papers)Shibing Wang (2 shared papers)Tiancheng Xu (2 shared papers)Shiqun Wang (3 shared papers)
In The Last Decade
Lingkai Kong
18 papers receiving 256 citations
Peers
Comparison fields: 5 of 50
- Oncology 108
- Genetics 101
- Biotechnology 28
- Geriatrics and Gerontology 8
- Cancer Research 26
Countries citing papers authored by Lingkai Kong
This map shows the geographic impact of Lingkai Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingkai Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingkai Kong more than expected).
Fields of papers citing papers by Lingkai Kong
This network shows the impact of papers produced by Lingkai Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingkai Kong. The network helps show where Lingkai Kong may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingkai Kong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 61 | |
| 2 | 2019 | 35 | |
| 3 | 2021 | 31 | |
| 4 | 2023 | 27 | |
| 5 | 2018 | 26 | |
| 6 | 2025 | 16 | |
| 7 | 2024 | 12 | |
| 8 | 2024 | 12 | |
| 9 | 2022 | 11 | |
| 10 | 2023 | 6 | |
| 11 | 2024 | 5 | |
| 12 | 2024 | 4 | |
| 13 | 2024 | 4 | |
| 14 | 2019 | 3 | |
| 15 | 2023 | 2 | |
| 16 | 2025 | 2 | |
| 17 | 2025 | 1 | |
| 18 | 2023 | 1 | |
| 19 | 2026 | 0 | |
| 20 | 2025 | 0 |
About Lingkai Kong
Lingkai Kong is a scholar working on Genetics, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 22 papers that have together received 259 indexed citations. Recurring topics across this work include Virus-based gene therapy research (8 papers), Ferroptosis and cancer prognosis (3 papers), Industrial Vision Systems and Defect Detection (2 papers), Cancer, Lipids, and Metabolism (2 papers), Cancer Research and Treatments (2 papers), RNA modifications and cancer (2 papers), CAR-T cell therapy research (2 papers) and Advanced Neural Network Applications (1 paper). The work is most often cited by research in Oncology (108 citations), Genetics (101 citations), Biotechnology (28 citations), Geriatrics and Gerontology (8 citations) and Cancer Research (26 citations). Lingkai Kong has collaborated with scholars based in China, Germany and Ireland. Frequent co-authors include Junhua Wu, Shuguang Zuo, Jie Dong, Jiwu Wei, Min Wei, Shibing Wang, Tiancheng Xu, Shiqun Wang, Chunping Jiang and Xiaosong Gu. Their work appears in journals such as Cell Reports Medicine, Journal of Experimental & Clinical Cancer Research, BMC Cancer, Applied Sciences and JCI Insight.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.